Todd G D, Bourne D W, McAllister R G
Ther Drug Monit. 1980;2(4):411-6.
This study was carried out to compare gas chromatography (GC) and high-pressure liquid chromatography (HPLC) procedures in the measurement of plasma levels of verapamil. Other analytic methods previously reported are not widely available (mass fragmentography) or are subject to interference from drug metabolites (spectrophotofluorometry). A single extraction and derivatization procedure was developed to prepare samples for either GC or HPLC analysis. The GC procedure used a nitrogen-specific detector; the HPLC, a fluorescence detector. In a 1--500 ng/ml range of verapamil concentrations, both methods resulted in good separation of verapamil from a major metabolite, norverapamil, and from compound D517, used as an internal standard. Intraassay variation was similar for both procedures, with only slightly higher interassay variability found for the GC technique. Excellent correlation was found during analysis of the same unknown samples by both methods (r = 0.97; p less than 0.001). Either assay procedure appears satisfactory for use in measurement of verapamil levels in plasma.
本研究旨在比较气相色谱法(GC)和高压液相色谱法(HPLC)测定维拉帕米血浆浓度的方法。先前报道的其他分析方法要么应用不广泛(质谱碎片分析法),要么易受药物代谢产物干扰(分光荧光法)。开发了一种单一的萃取和衍生化程序,用于制备GC或HPLC分析的样品。GC法使用氮特异性检测器;HPLC法使用荧光检测器。在维拉帕米浓度为1 - 500 ng/ml的范围内,两种方法都能将维拉帕米与主要代谢产物去甲维拉帕米以及用作内标的化合物D517良好分离。两种方法的批内变异相似,GC技术的批间变异仅略高。两种方法分析相同未知样品时相关性极佳(r = 0.97;p < 0.001)。两种测定方法用于测量血浆中维拉帕米水平似乎都令人满意。